Nanette Cocero, Ph.D., MBA

Nanette Cocero is the Global President of Pfizer Vaccines, leading the development, commercialization, and delivery of innovative vaccines to drive the prevention of serious and life-threatening conditions. With over 25 years of experience, Cocero is a recognized global leader with broad business acumen coupled with an extensive clinical background and scientific expertise. She leads a $6 billion global business and manages a diverse vaccine portfolio aimed at protecting lives at all stages, from infants to older adults.  
 
Cocero is Outgoing Chair of the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) Vaccine CEO Steering Committee, advocating for policies and practices that foster vaccine innovation while driving collaboration across the biopharmaceutical industry. In this position and her role at Pfizer, she has served as a key thought leader for the industry during the COVID-19 pandemic, accelerating the production of a potential COVID-19 vaccine and advocating for equitable access to diagnostics, therapeutics, and vaccines around the world. She also serves on the Leadership Council for the Milken Institute Center for the Future of Aging.
 
Cocero is a former Research Fellow for the University of Pennsylvania, Department of Pharmacology. She earned a BSc in chemistry from Cornell University, a PhD in pharmacology from the University of Pennsylvania, and an MBA from The Wharton Business School.